Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Can public-private partnership (PPP) improve hospitals' performance indicators?

Bastani P, Barati O, Sadeghi A, Ramandi S, Javan-Noughabi J.

Med J Islam Repub Iran. 2019 Feb 11;33:4. doi: 10.34171/mjiri.33.4. eCollection 2019.

2.

Effects of private and public health expenditure on health outcomes among countries with different health care systems: 2000 and 2014.

Raeesi P, Harati-Khalilabad T, Rezapour A, Azari S, Javan-Noughabi J.

Med J Islam Repub Iran. 2018 May 1;32:35. doi: 10.14196/mjiri.32.35. eCollection 2018.

3.

The cost-effectiveness of neoadjuvant chemotherapy in women with locally advanced breast cancer: Adriamycin and cyclophosphamide in comparison with paclitaxel and gemcitabine.

Javan-Noughabi J, Rezapour A, Kassani A, Hatam N, Ahmadloo N.

J Res Med Sci. 2018 Jun 6;23:57. doi: 10.4103/jrms.JRMS_644_17. eCollection 2018.

4.

Health care expenditure in the Islamic Republic of Iran versus other high spending countries.

Khosravi B, Soltani S, Javan-Noughabi J, Faramarzi A.

Med J Islam Repub Iran. 2017 Dec 6;31:71. doi: 10.14196/mjiri.31.71. eCollection 2017.

5.

Catastrophic Health Expenditure of Chronic Diseases: Evidence from Hamadan, Iran.

Rezapour A, Vahedi S, Khiavi FF, Esmaeilzadeh F, Javan-Noughabi J, Rajabi A.

Int J Prev Med. 2017 Dec 5;8:99. doi: 10.4103/ijpvm.IJPVM_104_17. eCollection 2017.

6.

Identification determinant factors on willingness to pay for health services in Iran.

Javan-Noughabi J, Kavosi Z, Faramarzi A, Khammarnia M.

Health Econ Rev. 2017 Nov 21;7(1):40. doi: 10.1186/s13561-017-0179-x.

Supplemental Content

Loading ...
Support Center